Sunitinib Malate Capsules
Reason Labeling: Label Mix-Up
2,277 recalls · Class II, newest first
Reason Labeling: Label Mix-Up
Reason Subpotent Drug
Reason CGMP Deviations
Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Reason CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Reason CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Reason CGMP violations.
Reason CGMP violations.
Reason Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
Reason Crystallization
Reason Defective Delivery System: The dip tube is clogged causing the spray not to work.
Reason CGMP deviations
Reason CGMP deviations
Reason Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Reason Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Reason Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.
Reason Failed Dissolution Specifications
Reason Microbial Contamination of Non-Sterile Product
Reason Microbial contamination of non-sterile Products -
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility